Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 10, 2004, Pages 1910-1915

  Zhang, Bo ^a   Fan, Ping ^a   Shimoji, Eiso ^a   Xu, Huali ^a   Takeuchi, Kazuma ^a   Bian, Cheng ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E containing high density lipoprotein; Capillary isotachophoresis; Cholesteryl ester transfer protein inhibition; Lysophosphatidylcholine; Paraoxonase (PON1); Platelet activating factor acetylhydrolase; Rabbits

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL ESTERIFICATION; CONFORMATION; CONTROLLED STUDY; ENZYME INHIBITION; ISOMER; ISOTACHOPHORESIS; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RABBIT;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; ELECTROPHORESIS, CAPILLARY; GLYCOPROTEINS; LIPOPROTEINS, HDL; LYSOPHOSPHATIDYLCHOLINES; RABBITS; SULFHYDRYL COMPOUNDS;

EID: 5344278234     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000143389.00252.bc     Document Type: Article

References (35)

1. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol. 1988;4(Suppl A): 5A-10A.
2. Barter PJ, Brewer HB, Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:160-167.
3. Yamashita S, Sprecher DL, Sakai N, Matsuzawa Y, Tarui S, Hui DY. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990;86:688-695.
4. de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, de Graaf J, Zwinderman AH, Posma JL, van Tol A, Kastelein JJ. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation. 2002;105:2159-2165.
5. Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, Magnus-Aryitey G, Cosgrove PG, Sand TM, Wester RT, Williams JA, Perlman ME, Bamberger MJ. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol. 2004;24:490-497.
6. Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med. 2004;350:1505-1515.
7. Dobiasova M, Frohlich J. Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio. Physiol Res. 1998;47:387-397.
8. Dobiasova M, Adler L, Ohta T, Frohlich J. Effect of labeling of plasma lipoproteins with [(3)H]cholesterol on values of esterification rate of cholesterol in apolipoprotein B-depleted plasma. J Lipid Res. 2000;41:1356-1357.
9. Frohlich J, Dobiasova M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49:1873-1880.
10. Dobiasova M, Frohlich JJ. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport. Clin Chim Acta. 1999;286:257-271.
11. Dobiasova M, Frohlich JJ. Assays of lecithin cholesterol acyltransferase (LCAT). Methods Mol Biol. 1998;110:217-230.
12. Dobiasova M, Frohlich J. Measurement of fractional esterification rate of cholesterol in plasma depleted of apolipoprotein B containing lipoprotein: methods and normal values. Physiol Res. 1996;45:65-73.
13. Dobiasova M, Stribrna J, Frohlich JJ. Relation of cholesterol esterification rate to the plasma distribution of high-density lipoprotein sub-classes in normal and hypertensive women. Clin Invest Med. 1995;18:449-454.
14. Dobiasova M, Frohlich JJ. Structural and functional assessment of high-density lipoprotein heterogeneity. Clin Chem. 1994;40:1554-1558.
15. 3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J Lipid Res. 1992;33:1411-1418.
16. Saku K, Zhang B, Ohta T, Arakawa K. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. J Am Coll Cardiol. 1999;33:436-443.
17. Schmitz G, Mollers C, Richter V. Analytical capillary isotachophoresis of human serum lipoproteins. Electrophoresis. 1997;18:1807-1813.
18. Bottcher A, Schlosser J, Kronenberg F, Dieplinger H, Knipping G, Lackner KJ, Schmitz G. Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions. J Lipid Res. 2000;41:905-915.
19. Barlage S, Frohlich D, Bottcher A, Jauhiainen M, Muller HP, Noetzel F, Rothe G, Schutt C, Linke RP, Lackner KJ, Ehnholm C, Schmitz G. ApoE-containing high densily lipoproleins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res. 2001;42:281-290.
20. Chiba H, Eto M, Fujisawa S, Akizawa K, Intoh S, Miyata O, Noda K, Matsuno K, Kobayashi K. Increased plasma apolipoprotein E-rich high-density lipoprotein and its effect on serum high-density lipoprotein cholesterol determination in patients with familial hyperalphalipoproteinemia due to cholesteryl ester transfer activity deficiency. Biochem Med Metab Biol. 1993;49:79-89.
21. Mitchell CD, King WC, Applegate KR, Forte T, Glomset JA, Norum KR, Gjone E. Characterization of apolipoprotein E-rich high density lipoproteins in familial lecithin:choleslerol acyltransferase deficiency. J Lipid Res. 1980;21:625-634.
22. Wilson HM, Patel JC, Russell D, Skinner ER. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta. 1993;220:175-187.
23. Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001;21:481-488.
24. Noto H, Kawamura M, Hashimoto Y, Satoh H, Hara M, Iso-o N, Togo M, Kimura S, Tsukamoto K. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency. Atherosclerosis. 2003;171:131-136.
25. Tselepis AD, John Chapman M. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler Suppl. 2002;3:57-68.
26. Shimoji E, Zhang B, Fan P, Saku K. Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits. Atherosclerosis. 2004;172:247-257.
27. Zhang B, Shimoji E, Fan P, Saku K. Metabolic background modulates the effects of cholesteryl ester transfer protein (CETP) inhibition on the kinetics, function, and composition of high density lipoprotein (HDL) particles. Circulation. 2003;108:IV-196 (abstract).
28. Moriyama K, Sasaki J, Arakawa F, Takami N, Maeda E, Matsunaga A, Takada Y, Midorikawa K, Yanase T, Yoshino G, et al. Two novel point mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in LCAT deficiency: LCAT (G873 deletion) and LCAT (Gly344->Ser). J Lipid Res. 1995;36:2329-2343.
29. Soutar AK, Knight BL, Myant NB. The characterization of lipoproteins in the high density fraction obtained from patients with familial lecithin: cholesterol acyltransferase deficiency and their interaction with cultured human fibroblasts. J Lipid Res. 1982;23:380-390.
30. Berard AM, Clerc M, Brewer B, Jr., Santamarina-Fojo S. A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency. Clin Chim Acta. 2001;314:131-139.
31. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem. 1996;271:30121-30125.
32. Taira K, Bujo H, Hirayama S, Yamazaki H, Kanaki T, Takahashi K, Ishii I, Miida T, Schneider WJ, Saito Y. LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro. Arterioscler Thromb Vasc Biol. 2001;21:1501-1506.
33. Li X, Kan HY, Lavrentiadou S, Krieger M, Zannis V. Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1-165 domain of ApoE suffices for receptor binding. J Biol Chem. 2002;277:21149-21157.
34. Bultel-Brienne S, Lestavel S, Pilon A, Laffont I, Tailleux A, Fruchart JC, Siest G, Clavey V. Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins. J Biol Chem. 2002;277:36092-36099.
35. Thuahnai ST, Lund-Katz S, Anantharamaiah GM, Williams DL, Phillips MC. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. J Lipid Res. 2003;44:1132-1142.